These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11272262)

  • 1. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff.
    Richardson LP; Wiseman SW; Malani PN; Lyons MJ; Kauffman CA
    Microb Drug Resist; 2000; 6(4):327-30. PubMed ID: 11272262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
    Anglim AM; Klym B; Byers KE; Scheld WM; Farr BM
    Arch Intern Med; 1997 May; 157(10):1132-6. PubMed ID: 9164379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci.
    Guglielmo BJ; Dudas V; Maewal I; Young R; Hilts A; Villmann M; Gibbs L; Gropper M; Jacobs R
    Jt Comm J Qual Patient Saf; 2005 Aug; 31(8):469-75. PubMed ID: 16156195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures.
    Hayden MK; Bonten MJ; Blom DW; Lyle EA; van de Vijver DA; Weinstein RA
    Clin Infect Dis; 2006 Jun; 42(11):1552-60. PubMed ID: 16652312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vancomycin resistant enterococci in Austria].
    Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.
    ;
    Can Commun Dis Rep; 1997 Dec; 23 Suppl 8():i-iv, 1-16, i-iv, 1-19. PubMed ID: 11195274
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin-resistant Enterococcus in pediatric oncology patients: balancing infection prevention and family-centered care.
    Singh J; Esparza S; Patterson M; Vogel K; Patel B; Gornick W
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):227-31. PubMed ID: 22627579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
    Thomas AR; Cieslak PR; Strausbaugh LJ; Fleming DW
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin use in 2 Ontario tertiary care hospitals: a survey.
    Kwan T; Lin F; Ngai B; Loeb M
    Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interventional program to improve antibiotic use.
    Feucht CL; Rice LB
    Ann Pharmacother; 2003 May; 37(5):646-51. PubMed ID: 12708938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience].
    Benzer D; Yavuzcan Öztürk D; Gürsoy T; Ocalmaz MS; Karatekin G; Ovalı HF
    Mikrobiyol Bul; 2012 Oct; 46(4):682-8. PubMed ID: 23188582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vancomycin (VCM) resistant enterococci (VRE)].
    Fujimoto S; Ike Y; Takahashi A; Yomoda S; Murakami M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():182-9. PubMed ID: 12717969
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
    Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
    Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E; Cataldo MA
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterococcus spp. colonized in the gastrointestinal tract of patients in hemato-oncology and intensive care units and their resistance profiles to vancomycin].
    Menteş O; Balci I
    Mikrobiyol Bul; 2007 Oct; 41(4):585-9. PubMed ID: 18173078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
    Ott M; Wirick H
    Can Oper Room Nurs J; 2008 Mar; 26(1):21-4, 26-9, 32. PubMed ID: 18444472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use.
    Kolar M; Vagnerova I; Latal T; Urbanek K; Typovska H; Hubacek J; Papajik T; Raida L; Faber E
    New Microbiol; 2002 Apr; 25(2):205-12. PubMed ID: 12019727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.
    Lautenbach E; LaRosa LA; Marr AM; Nachamkin I; Bilker WB; Fishman NO
    Clin Infect Dis; 2003 Feb; 36(4):440-6. PubMed ID: 12567301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus.
    Morgan AS; Brennan PJ; Fishman NO
    Ann Pharmacother; 1997 Sep; 31(9):970-3. PubMed ID: 9296233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.